Table 2. Measures used & key findings.
| Citation | Measures Used | Key Findings Post-NFT |
|---|---|---|
| Rozelle | BASRS, BNT, BDAE, AB, | + speech abilities |
| 1995 | SCWT, BSI, CCPT, RPM | + neuropsychological batteries |
| + short-term memory | ||
| Additional: VI, HWS, STR, NA | + improvement of anxiety and depression | |
| + visual tracking and ability to focus | ||
| + tinnitus cessation | ||
| *tests of statistical significant not performed/not indicated for pre-post measures* | ||
| Bearden | BSI | + NA subscales (TMT, WMS, DS). Significant improvements on some |
| 2003 | + BSI score | |
| Additional: RST, NA | + RST | |
| *tests of statistical significance were run indicating significant improvements on measures, but p-values were not indicated* | ||
| Doppelmayr | RBMT | Experiment 1: significant effect for time (pre to post) and group (NFT) on RBMT |
| 2007 | - significant interaction between group and time on RBMT | |
| = RBMT remained stable over time for the control Relaxation control group | ||
| Experiment 2: all groups showed improvements in RBMT over time | ||
| Group and interaction did not reach significance | ||
| *for both studies: tests of statistical significance were run indicating significant improvements on measures, but p-values were not indicated* | ||
| Cannon | SDC | Symptoms improved from “very problematic” at baseline to “somewhat better” |
| 2010 | Positive comments from participant: “I’m more with it”, “… more confident”, “people can’t tell I’ve stroked” | |
| * cessation of anti-depressants @ session 15 * | ||
| *tests of statistical significant not performed/not indicated for pre-post measures* | ||
| Toppi | RAVLT & CBTT | Participant 1: |
| 2014 | +SMR amplitude | |
| + RAVLT & CBTT (p<0.05) | ||
| + SMT (p<0.05) | ||
| Participant 2: | ||
| = SMR amplitude | ||
| = RAVLT & CBTT | ||
| - STM | ||
| Mroczkowska | BADLI, GKS, BVRT, CTT, MMSE, BDI, RPM, EPQ, TOPS | + concentration |
| 2014 | + visual perception | |
| + mood | ||
| + speech | ||
| *tests of statistical significant not performed/not indicated for pre-post measures* | ||
| Cho | MVPT | MVPT: |
| 2015 | + NFT: raw score (p<0.01), time (p<0.001)all values (sig) | |
| + Control: raw score (p<0.01), FC, time (p<0.01)sig) | ||
| Significant difference between groups (time and score, p<0.05) |
Abbreviations: Apraxia Battery (AB); Barthel Activities of Daily Living Index (BADLI); Boston Aphasia Severity Rating Scale (BASRS); Boston Diagnostic Aphasia Examination (BDEA); Beck Depression Inventory (BDI); Boston Naming Test (BNT); Brief Symptom Inventory (BSI); Benton Visual Retention Test (BVRT); Corsi Block Tapping Test (CBTT); Conners Continuous Performance Test (CCPT); cognitive deficit (CD); Colour Trails Test (CTT); Digit Span (DS); Eysenck Personality Questionnaire (EPQ); Goodglass and Kaplan Scale (GKS); Hand Writing Sample (HWS); Mini Mental State Exam (MMSE); Motor-Free Visual Perception Test (MVPT); Neuropsychological Assessment (NA); Rey Auditory Verbal Learning Test (RAVLT); Rivermead Behavioural Memory Test (RBMT); Ravens Progressive Matrices (RPM); Reading Speed Test (RST); Self-Developed Checklist/Short Answer Interview (SDC); Speech Therapy Report (STR); Stroop Colour and Word Test (SCWT); Sternberg Memory Test (SMT); Trails Making Test (TMT); Tools for Optimal Performance (TOPS); Video Interview (VI); Wechsler Memory Scale (WMS). Symbols: + improvement in performance, —decrements in performance, = no change.